Episode Details
Back to Episodes
Global Cannabis Trends: Deals, Regulations, and Supply Chain Challenges
Published 8 months, 2 weeks ago
Description
In the past 48 hours, the cannabis industry has experienced significant developments across global markets, marked by new deals, regulatory moves, and continued volatility in supply and demand. One headline event is Canadian retailer High Tide’s acquisition of a majority stake in Remexian Pharma GmbH, making High Tide a major player in Germany’s fast-growing medical cannabis market. Germany imported a record 43.3 metric tonnes of medical cannabis in Q2 2025, a 15 percent increase from Q1. Canada supplied nearly half, strengthening its role as the top exporter. Remexian contributed 16 percent of this volume, reporting annualized revenue of 70 million euros for the first half of 2025. High Tide aims for continued growth even if pending restrictions on telemedicine and mail-order cannabis sales are enacted, asserting that the market will adjust and rebound after any regulatory changes.
Meanwhile, Tilray Medical announced a new partnership with Italian pharma group Molteni, expanding patient access to cannabis extracts and medical education. This reflects broader EU market momentum, with major suppliers consolidating distribution and focusing on pain management therapies.
In the US, recent regulatory news centers on Representative Greg Steube’s Marijuana 1-to-3 Act, a bill to move cannabis to federal Schedule III status. Industry stakeholders are watching closely, as rescheduling could catalyze wider legalization at the state level and open new investment and banking pathways.
On the business front, Greenlane Holdings shifted its strategy from cost-cutting to growth in cannabis accessories and sustainable packaging. Despite reporting a Q2 loss of 3.2 million dollars, partnerships and warehouse consolidation have improved margins and positioned Greenlane as a leader in the eco-friendly packaging market, projected to grow at a 17.4 percent compound rate through 2034.
Conversely, supply chain disruptions remain a challenge. Glass House, a leading California cultivator, scaled back production and expects a drop in Q3 revenue by up to 30 million dollars following recent ICE raids that reduced its workforce. The company is delaying harvests and pivoting operations, with plans for a Q4 rebound. Executives emphasize resilience, citing the need to be “bulletproof” against future regulatory and labor shocks.
Consumer behavior in mature US markets like Washington state reflects a post-pandemic slump, with Q1 2025 cannabis sales down 25 percent compared to Q1 2021, as novelty wanes and market saturation sets in.
Overall, the past week saw consolidation among industry leaders, aggressive international expansion, regulatory catalysts, and ongoing pressure from supply chain and labor disruptions. Compared to last quarter, companies are focusing on strategic partnerships and operational efficiency, preparing for near-term headwinds and long-term global growth.
For great deals today, check out https://amzn.to/44ci4hQ
This content was created in partnership and with the help of Artificial Intelligence AI
Meanwhile, Tilray Medical announced a new partnership with Italian pharma group Molteni, expanding patient access to cannabis extracts and medical education. This reflects broader EU market momentum, with major suppliers consolidating distribution and focusing on pain management therapies.
In the US, recent regulatory news centers on Representative Greg Steube’s Marijuana 1-to-3 Act, a bill to move cannabis to federal Schedule III status. Industry stakeholders are watching closely, as rescheduling could catalyze wider legalization at the state level and open new investment and banking pathways.
On the business front, Greenlane Holdings shifted its strategy from cost-cutting to growth in cannabis accessories and sustainable packaging. Despite reporting a Q2 loss of 3.2 million dollars, partnerships and warehouse consolidation have improved margins and positioned Greenlane as a leader in the eco-friendly packaging market, projected to grow at a 17.4 percent compound rate through 2034.
Conversely, supply chain disruptions remain a challenge. Glass House, a leading California cultivator, scaled back production and expects a drop in Q3 revenue by up to 30 million dollars following recent ICE raids that reduced its workforce. The company is delaying harvests and pivoting operations, with plans for a Q4 rebound. Executives emphasize resilience, citing the need to be “bulletproof” against future regulatory and labor shocks.
Consumer behavior in mature US markets like Washington state reflects a post-pandemic slump, with Q1 2025 cannabis sales down 25 percent compared to Q1 2021, as novelty wanes and market saturation sets in.
Overall, the past week saw consolidation among industry leaders, aggressive international expansion, regulatory catalysts, and ongoing pressure from supply chain and labor disruptions. Compared to last quarter, companies are focusing on strategic partnerships and operational efficiency, preparing for near-term headwinds and long-term global growth.
For great deals today, check out https://amzn.to/44ci4hQ
This content was created in partnership and with the help of Artificial Intelligence AI